4
Changes in Ownership
Tarsus Pharmaceuticals, Inc. Filed Acc 0001788542-26-000003
Options or other derivatives
- Chief Commercial Officer acquired 50,030 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Mottiwala Aziz · Chief Commercial Officer
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-03-05 | Grant or award : show line 1 in the form Stock Option (right to buy) | +30,724 | 30,724 | D |
| 2026-03-05 | Grant or award : show line 2 in the form Restricted Stock Units | +19,306 | 19,306 | D |
Loading xslF345X05/wk-form4_1773086801.xml…